1. A novel modular platform for adoptive T cell therapy combining bispecific antibodies with synthetic agonistic receptors. (March 2019) Authors: Karches, C.H.; Benmebarek, M.; Schmidbauer, M.L.; Kurzay, M.; Klaus, R.; Lesch, S.; Cadilha, B.; Rataj, F.; Heise, C.; Geiger, M.; Murr, R.; Berg, J.vom; Jastroch, M.; Lamp, D.; Duewell, P.; Niederfellner, G.; Sustmann, C.; Endres, S.; Klein, C.; Kobold, S. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abstracts from the 4th ImmunoTherapy of Cancer Conference: Prague, Czech Republic. 20–22 March 2017. (20th March 2017) Authors: Ženka, J.; Caisová, V.; Uher, O.; Nedbalová, P.; Kvardová, K.; Masáková, K.; Krejčová, G.; Paďouková, L.; Jochmanová, I.; Wolf, K. I.; Chmelař, J.; Kopecký, J.; Loumagne, L.; Mestadier, J.; D'agostino, S.; Rohaut, A.; Ruffin, Y.; Croize, V.; Lemaître, O.; Sidhu, S. S. Journal: Journal for immunotherapy of cancer Issue: Volume 5(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Arming T cells with activating FcγRIIIa receptors for antibody redirected lysis of cancer cells. (March 2018) Authors: Jacobi, S.J.; Rataj, F.; Asang, F.; Stoiber, S.; Benmebarek, M.; Klaus, R.; Endres, S.; Klein, C.; Kobold, S. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 1 Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Arming T cells with C-X-C-motive receptor 6 enables adoptive T cell therapy of pancreatic cancer. (March 2019) Authors: Lesch, S.; Blumenberg, V.; Stoiber, S.; Ogonek, J.; Cadilha, B.; Dantes, Z.; Rataj, F.; Dorman, K.; Lutz, J.; Karches, C.; Heise, C.; Grassmann, S.; Megens, R.; Ruehland, S.; Di Pilato, M.; Pruessmann, J.; Ormanns, S.; Reischer, A.; Duewell, P.; Schnurr, M. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Arming T cells with C-X-C-motive receptor 6 enhances infiltration of pancreatic cancer patient-derived organoids. (March 2019) Authors: Ogonek, J.; Lutz, J.; Dantes, Z.; Lesch, S.; Stoiber, S.; Schuebel, M.; Voelkl, L.; Ormanns, S.; Reichert, M.; Endres, S.; Kobold, S. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cancer cells regulate Interleukin-22 production to promote tumor growth. (March 2018) Authors: Voigt, C.; May, P.; Gottschlich, A.; Markota, A.; Wenk, D.; Gerlach, I.; Suárez Gosálvez, J.; Ruzicka, T.; Kraechan, A.; Voigt, S.; Stathopoulos, G.; Arendt, K.; Heise, C.; Rataj, F.; Janssen, K.; Königshoff, M.; Winter, H.; Himsl, I.; Thasler, W.; Schnurr, M. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Characterization of bispecific antibodies that drive synthetic agonistic receptor - transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models. (March 2019) Authors: Benmebarek, M.; Karches, C.H.; Schmidbauer, M.L.; Kurzay, M.; Klaus, R.; Geiger, M.; Rataj, F.; Cadilha, B.; Lesch, S.; Heise, C.; Murr, R.; Berg, J.vom; Jastroch, M.; Lamp, D.; Niederfellner, G.; Sustmann, C.; Endres, S.; Klein, C.; Kobold, S. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. G-Protein coupled receptor 55 deficiency promotes atherosclerosis and inflammation in mice. (August 2018) Authors: Hering, D.; Guillamat-Prats, R.; Rami, M.; Kobold, S.; Döring, Y.; Steffens, S. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Mesothelin-targeted bispecific antibodies drive synthetic agonistic receptor – Transduced T cells to mediate specific and conditional therapy of human pancreatic cancer models. (March 2018) Authors: Benmebarek, M.; Karches, C.; Schmidbauer, M.; Kurzay, M.; Klaus, R.; Geiger, M.; Rataj, F.; Cadilha, B.; Keyl, J.; Lesch, S.; Heise, C.; Murr, R.; vom Berg, J.; Jastroch, M.; Lamp, D.; Niederfellner, G.; Sustmann, C.; Endres, S.; Klein, C.; Kobold, S. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 1 Page Start: S20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Proof of concept and mode of action of a novel modular platform for adoptive T cell therapy combining bispecific antibodies with synthetic agonistic receptors. (March 2018) Authors: Karches, C.; Benmebarek, M.; Schmidbauer, M.; Kurzay, M.; Klaus, R.; Geiger, M.; Lesch, S.; Cadilha, B.; Rataj, F.; Heise, C.; Murr, R.; vom Berg, J.; Jastroch, M.; Lamp, D.; Duewell, P.; Niederfellner, G.; Sustmann, C.; Endres, S.; Klein, C.; Kobold, S. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 1 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗